Open-Label Clinical Trial Evaluating the Impact of a Multi-Strain Commensal Probiotic Dietary Supplement on Gastrointestinal Microbiota Composition, Functional Gastrointestinal Markers, and Gastrointestinal Symptoms
Starting soon · Not applicable
Conditions studied: Gastrointestinal, Microbiota
In brief
A single-arm, open-label prospective study will be conducted evaluating the impact of 8 weeks of supplementation at the manufacturer-recommended dose of Complete Commensal Probiotic™ on the GI-MAP stool test panel (Diagnostic Solutions Laboratory, Alpharetta, GA), gastrointestinal symptoms, digestion-associated quality of life. and overall physical health, mental health, and anxiety.
Key facts
- Study ID
- NCT07720362
- Run by
- OvationLab
- People needed
- 25
- Starts
- 2026-07-21
- Expected to finish
- 2026-11-01
- Last updated by the study team
- 2026-07-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult females or males age ≥ 18 years
- At least moderate gastrointestinal distress, defined as a score of ≥ 4 on any domain of the Gastrointestinal Symptoms Rating Scale (GSRS) at screening
- Ability to read and speak English
- Ability and willingness to collect an at-home stool sample for GI-MAP testing
You may not qualify if…
- Current or recent (within the prior 90 days) use of a probiotic dietary supplement
- Current or recent (within the prior 90 days) use of systemic antibiotics, antifungals, or antiparasitic medications
- Known allergies to any ingredients in the product
- Currently pregnant or lactating women or women planning to become pregnant in the next 8 weeks
- Current diagnosis of inflammatory bowel disease (Crohn's disease or ulcerative colitis), celiac disease, active gastrointestinal malignancy, or other chronic health condition (e.g., cancer, heart failure, history of pancreatitis, type I or II diabetics on insulin) deemed clinically contraindicated for the study protocol
- Severely immunocompromised status (e.g., active chemotherapy, post-transplant immunosuppression, advanced HIV)
- Participants unable to provide consent
Where it is running
- OvationLab — Richmond, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.